Goat Polyclonal ENV antibody. Suitable for WB and reacts with Human immunodeficiency virus samples.
Preservative: 0.1% Sodium azide
Constituents: 0.0268% PBS
WB | |
---|---|
Human immunodeficiency virus | Expected |
Species | Dilution info | Notes |
---|---|---|
Species Human immunodeficiency virus | Dilution info - | Notes Major band seen in WB at 41kDa and a minor band at 20kDa.Dilution optimised using Chromogenic detection. |
Select an associated product type
Envelope glycoprotein gp160. Oligomerizes in the host endoplasmic reticulum into predominantly trimers. In a second time, gp160 transits in the host Golgi, where glycosylation is completed. The precursor is then proteolytically cleaved in the trans-Golgi and thereby activated by cellular furin or furin-like proteases to produce gp120 and gp41. Surface protein gp120. Attaches the virus to the host lymphoid cell by binding to the primary receptor CD4. This interaction induces a structural rearrangement creating a high affinity binding site for a chemokine coreceptor like CXCR4 and/or CCR5. Acts as a ligand for CD209/DC-SIGN and CLEC4M/DC-SIGNR, which are respectively found on dendritic cells (DCs), and on endothelial cells of liver sinusoids and lymph node sinuses. These interactions allow capture of viral particles at mucosal surfaces by these cells and subsequent transmission to permissive cells. HIV subverts the migration properties of dendritic cells to gain access to CD4+ T-cells in lymph nodes. Virus transmission to permissive T-cells occurs either in trans (without DCs infection, through viral capture and transmission), or in cis (following DCs productive infection, through the usual CD4-gp120 interaction), thereby inducing a robust infection. In trans infection, bound virions remain infectious over days and it is proposed that they are not degraded, but protected in non-lysosomal acidic organelles within the DCs close to the cell membrane thus contributing to the viral infectious potential during DCs' migration from the periphery to the lymphoid tissues. On arrival at lymphoid tissues, intact virions recycle back to DCs' cell surface allowing virus transmission to CD4+ T-cells. Transmembrane protein gp41. Acts as a class I viral fusion protein. Under the current model, the protein has at least 3 conformational states: pre-fusion native state, pre-hairpin intermediate state, and post-fusion hairpin state. During fusion of viral and target intracellular membranes, the coiled coil regions (heptad repeats) assume a trimer-of-hairpins structure, positioning the fusion peptide in close proximity to the C-terminal region of the ectodomain. The formation of this structure appears to drive apposition and subsequent fusion of viral and target cell membranes. Complete fusion occurs in host cell endosomes and is dynamin-dependent, however some lipid transfer might occur at the plasma membrane. The virus undergoes clathrin-dependent internalization long before endosomal fusion, thus minimizing the surface exposure of conserved viral epitopes during fusion and reducing the efficacy of inhibitors targeting these epitopes. Membranes fusion leads to delivery of the nucleocapsid into the cytoplasm.
env
Envelope glycoprotein gp160, Env polyprotein, env
Goat Polyclonal ENV antibody. Suitable for WB and reacts with Human immunodeficiency virus samples.
Preservative: 0.1% Sodium azide
Constituents: 0.0268% PBS
Ab20890 is purified by sodium sulfate precipitation and ion-exchange chromatography. The antiserum has not been adsorbed to remove anti-beta-galactosidase activity.
Abcam is leading the way to address reproducibility in scientific research with our highly validated recombinant monoclonal and recombinant multiclonal antibodies. Search & select one of Abcam's thousands of recombinant alternatives to eliminate batch-variability and unnecessary animal use.
If you do not find a host species to meet your needs, our catalogue and custom Chimeric range provides scientists the specificity of Abcam's RabMAbs in the species backbone of your choice. Remember to also review our range of edited cell lines, proteins and biochemicals relevant to your target that may help you further your research goals.
Abcam antibodies are extensively validated in a wide range of species and applications, so please check the reagent specifications meet your scientific needs before purchasing. If you have any questions or bespoke requirements, simply visit the Contact Us page to send us an inquiry or contact our Support Team ahead of purchase.
The HIV1 gp41 protein also known as the gp41 HIV protein is a glycoprotein that plays a mechanical role in the virus's capacity to fuse with host cells. This protein is 41 kDa in mass and is part of the viral envelope expressed on the surface of the HIV virus. Gp41 works closely with the gp120 protein to facilitate the fusion process a critical step in viral entry into lymphocytes. The 1d4 is sometimes used to refer to certain related domains or epitopes within the gp41 structure.
During the infection process gp41 acts by mediating membrane fusion between the HIV viral envelope and the host cell membrane. It forms part of the Env complex consisting of gp120 and gp41 proteins which together create the functional envelope glycoprotein spike on the virus. This spike binds to receptors on the host cell such as the CD4 molecule which initiates changes that reveal the gp41 protein allowing it to insert into the host cell membrane and pull the viral and cellular membranes together.
Involving HIV1 gp41 and its associated proteins the gp41 protein is a critical player in the viral entry pathway. After gp120 binds to the CD4 receptor and coreceptors such as CCR5 or CXCR4 on the host cell this conformational change exposes gp41 to carry out the fusion of viral and host membranes. The Env complex through gp41 and gp120 proteins coordinates this entry process integrating the viral genetic material with the host genome which is important for HIV propagation.
Involving the HIV1 gp41 protein it is directly related to the progression of HIV/AIDS. Gp41's function in viral entry makes it a target for antiviral drugs and vaccine development as inhibiting gp41 could block the virus from invading host cells. The interplay with gp120 and the interaction with host proteins like CD4 highlight the potential for gp41 as a therapeutic target in efforts to prevent or treat HIV infection.
We have tested this species and application combination and it works. It is covered by our product promise.
We have not tested this specific species and application combination in-house, but expect it will work. It is covered by our product promise.
This species and application combination has not been tested, but we predict it will work based on strong homology. However, this combination is not covered by our product promise.
We do not recommend this combination. It is not covered by our product promise.
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com